A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
PHASE3
The purpose of this trial is to examine the efficacy and safety of once-wee...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)
PHASE3
This is a non-inferiority study comparing omarigliptin with sitagliptin in ...
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
PHASE3
This study will examine the safety and efficacy of the addition of omarigli...